Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
No check the date of this well after the split
12/31/2021 SABBY CAPITAL LLC Bought 250.8 Thousand shares of PharmaCyte Biotech Inc and holds over 1 million shares
The truth is in the filings and BAM PMCB will fly very soon. The IND hold will be lifted and any shares that were bought down here will make huge profits.
One of the richest Wall Street investors bought 88,000 shares and he knows the right time to be buying shares of PMCB ck the filings
Well we finally got back into CELH again working out nice so far up 20% in less than a week since we bought that beat up price. Good luck and keep drinking the product..........It should of never traded up to $110 and then back under $40 but thats when a real investor takes advantage of extremes $$$$$
lol read the date of the filing on PMCB its current. Its not from yrs ago when the stock was above $50.00 and I was selling.
read the filing and see all the smart money that now owns PMCB. Its in the SEC filings:
Smart money buying up the shares $$$$$$ These owners did not buy at $50.00 like some did they bought down here and will make many times the amount invested. When the good news hit the tape PMCB will fly...
Largest Quarterly Institutional
Transactions
Latest Institutional Activity
12/31/2021 SABBY CAPITAL LLC Bought 250.8 Thousand shares of PharmaCyte Biotech Inc
12/31/2021 CAROLINA WEALTH ADVISORS LLC Bought shares of PharmaCyte Biotech Inc
12/31/2021 BLUE BELL PRIVATE WEALTH MANAGEM... Bought shares of PharmaCyte Biotech Inc
Top 10 Owners of PharmaCyte Biotech Inc
Stockholder Stake Shares
owned Total value ($) Shares
bought / sold Total
change
Sabby Capital LLC 6.09% 1,260,928 3,152,320 +250,782 +24.83%
Iroquois Capital Management LLC 5.06% 1,048,646 2,621,615 +1,048,646 --
T. Rowe Price Associates, Inc. (I... 0.65% 133,600 334,000 +133,600 --
Schonfeld Strategic Advisors LLC 0.43% 88,200 220,500 +88,200 -- He is a billionaire and I am friends with him and one of the smartest investors on wall street
Susquehanna Investment Group LLC 0.24% 49,700 124,250 +49,700 --
Geode Capital Management LLC 0.23% 46,610 116,525 +46,610 --
NorthRock Partners LLC 0.18% 37,164 92,910 +37,164 --
Shay Capital LLC 0.07% 14,606 36,515 +14,606 --
Tower Research Capital LLC 0.03% 7,070 17,675 +7,070 --
UBS Securities LLC 0.02% 3,390 8,475 +3,390 --
Top 10 Mutual Funds Holding PharmaCyte Biotech Inc
Mutual fund Stake Shares
owned Total value ($) Shares
bought Total
change
Vanguard Total Stock Market Index... 2.85% 590,900 1,477,250 +590,900 --
AST T Rowe Price Growth Opportuni... 0.20% 41,700 104,250 0 0.00%
Fidelity Nasdaq Composite Index F... 0.13% 26,211 65,528 0 0.00%
Fidelity Extended Market Index Fu... 0.12% 24,616 61,540 0 0.00%
Vanguard Extended Market Index Fu... 0.10% 20,661 51,653 0 0.00%
SunAmerica Series Trust - SA T Ro... 0.03% 6,500 16,250 +6,500 --
Fidelity Total Market Index Fund 0.01% 2,452 6,130 0 0.00%
Vanguard Invt. Fds. ICVC - US Equ... 0.01% 2,105 5,263 0 0
Have a great day....................
Smart money buying up the shares $$$$$$
Largest Quarterly Institutional
Transactions
Latest Institutional Activity
12/31/2021 SABBY CAPITAL LLC Bought 250.8 Thousand shares of PharmaCyte Biotech Inc
12/31/2021 CAROLINA WEALTH ADVISORS LLC Bought 2.00 shares of PharmaCyte Biotech Inc
12/31/2021 BLUE BELL PRIVATE WEALTH MANAGEM... Bought 2.00 shares of PharmaCyte Biotech Inc
Top 10 Owners of PharmaCyte Biotech Inc
Stockholder Stake Shares
owned Total value ($) Shares
bought / sold Total
change
Sabby Capital LLC 6.09% 1,260,928 3,152,320 +250,782 +24.83%
Iroquois Capital Management LLC 5.06% 1,048,646 2,621,615 +1,048,646 --
T. Rowe Price Associates, Inc. (I... 0.65% 133,600 334,000 +133,600 --
Schonfeld Strategic Advisors LLC 0.43% 88,200 220,500 +88,200 --
Susquehanna Investment Group LLC 0.24% 49,700 124,250 +49,700 --
Geode Capital Management LLC 0.23% 46,610 116,525 +46,610 --
NorthRock Partners LLC 0.18% 37,164 92,910 +37,164 --
Shay Capital LLC 0.07% 14,606 36,515 +14,606 --
Tower Research Capital LLC 0.03% 7,070 17,675 +7,070 --
UBS Securities LLC 0.02% 3,390 8,475 +3,390 --
Top 10 Mutual Funds Holding PharmaCyte Biotech Inc
Mutual fund Stake Shares
owned Total value ($) Shares
bought Total
change
Vanguard Total Stock Market Index... 2.85% 590,900 1,477,250 +590,900 --
AST T Rowe Price Growth Opportuni... 0.20% 41,700 104,250 0 0.00%
Fidelity Nasdaq Composite Index F... 0.13% 26,211 65,528 0 0.00%
Fidelity Extended Market Index Fu... 0.12% 24,616 61,540 0 0.00%
Vanguard Extended Market Index Fu... 0.10% 20,661 51,653 0 0.00%
SunAmerica Series Trust - SA T Ro... 0.03% 6,500 16,250 +6,500 --
Fidelity Total Market Index Fund 0.01% 2,452 6,130 0 0.00%
Vanguard Invt. Fds. ICVC - US Equ... 0.01% 2,105 5,263 0 0
Well like I said when NIO was 42.00 it is a great short and we made a killing on this it got cut in half. We covered our shorts and now we are flat on the position. With what we made we could probably by 4 or 5 of their vehicles. Good luck to all it might be a buy here but there are many other places to put good money to work. Have a great weekend
Like I said when it was above 7.00 plus Short it shares will be hitting the mkt. We did cover our short in the low 4.00 level. Have a great day.........
My son made a good score on ECOR for the Jan effect the gift came quicker than my son thought it would he sold over 300k shares above .90. I believe in Vagus nerve work for surgery and other relaxation Techniques. I have invested in another company that is way ahead of ECOR and I see ECOR moving forward. We rebought some shares on the dip back to .70 but not as many only 50k. Lets see what happens these cheap stocks are just not the place to put large sums of money. Good luck to all ECOR shareholders
maybe so it is time to buy... KW said we should be done with all that was asked for by the FDA by the end of this 1/4. NICE IMO there is NO WAY we dont get the hold lifted now. The FDA will have all the info they asked for.
This does sound familiar--same as the CEO running BZWR recruiting names to promote BZWR:
"The credibility of Theranos was attributed in part to ( Elizabeth) Holmes's personal connections and ability to recruit the support of influential people, including Henry Kissinger, George Shultz, Jim Mattis, and Betsy DeVos, all of whom had served or would go on to serve as U.S. presidential cabinet officials"
LMAO the CEO must of put some "secret sauce" on the other 2 million dollars they were going to get. Now they are holding off on the full funding. Sounds like a major scam to me. Im thinking a reverse split is the next thing to be hearing from this stinky pinky. What is it this company sells and who needs it lol ????
I liked the presentation. The most important part was that he said we should be done with all that was asked for by the FDA by the end of this 1/4. NICE IMO there is NO WAY we dont get the hold lifted now. The FDA will have all the info they asked for.
From todays filing it shows another 250,000 shares was bought by an institution guess who it was lol
Well today anyone can buy it in the 6s. Now it is easy to see why its on our short list. Happy New Yr
lol Im on the beach and I see this text from one of my interns looking to make us money on the Jan effect. Hes showing me why he thinks ASTR is not a buy but a major short. Its off the list for the JAN effect and on the short list being that there will be a flood of shares hitting the mkt. I would think any one rookie in the mkt could see this. "As a courtesy, the Company would like to remind any remaining holders of Redeemable Warrants that if the remaining approximately 11.3 million Redeemable Warrants are not exercised prior to the Redemption Date, they will be redeemed at the redemption price of $0.10 per Redeemable Warrant.
Happy New yr......................
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on the development and commercialization of first-in-class critical care products, with a pipeline of anti-infectives in adjunct cancer care, oncology, stem cell therapy and unique prescription products.
I feel it will be a big winner coming into the new yr.
Maxim Group analyst Michael Okunewitch initiates coverage on Citius Pharmaceuticals (NASDAQ:CTXR) with a Buy rating and announces Price Target of $4.
We took a position in CTXR after the upgrade in early Dec looking for a double here.
Citius Pharmaceuticals, Inc. Reports Fiscal Full Year 2021 Financial Results and Provides Business Update
$70.1 million in cash and cash equivalents as of September 30, 2021 to advance pipeline
Completed treatment phase of Pivotal Phase 3 trial in cancer immunotherapy I/ONTAK for the treatment of cutaneous T- cell lymphoma
Independent Data Monitoring Committee recommended continuing the Mino-Lok(R) Phase 3 clinical superiority trial as planned without modifications; no safety concerns identified
Net cash about $4.20 per share . Stock is at $2.50... Hegde funds love a no risk play that why we buy the discounts...$$$
BZ: PharmaCyte Biotech Reports Q2 2021 Cash On Hand $87M. At todays price we are a good take over play. We have 4.15 or so per shares of cash so we are trading at a discount per cash on hand per share of 1.75 per share. That alone is going to give us a buy rating soon and more institutional buyers. The list is long already of institutions holding shares of PMCB. Here is a link to see the the holdings:https://money.cnn.com/quote/shareholders/shareholders.html?symb=PMCB&subView=institutional
Have a great day...................
Business Warrior Cor (BZWR)
0.077 ? -0.0004 (-0.52%)
Volume: 346,504 @12/15/21 3:52:41 PM
big buyer today watch for the after mkt print
Well lets see what you have here 87 million dollars to go forward that was raised from institutional investors that know much more than the avg fish swimming down Wall Street. Now PMCB has all the funds to go forward with the trial and change the way cancer could be treated in the future. Some are haters because they lost all their money buying at the wrong time. Well today is the right time to buy and look at the links that I have posted of the smart money that now holds shares in PMCB. So timing was so wrong and some have lost but it will be sweet justice to see PMCB get the IND and go to 50.00 plus dollars now that the outstanding shares are only 20 mil. Watch learn and be nice to all.........................Ive seen the same thing happen to many other companies over my yrs of being in the mkt. One went to .20 and then moved to over 100 dollars and that one was my retrirement money over 15 million made and the best was it was in my Roth acct. Timing is everything in life and the stock market and making money, Have a great day and merry Christmas to all ...............
Could BZWR go to the grey market????? then dont worry about fees. When you try to sell they might say To who there is no market. That could very well be the next step to happen good luck. Pink stocks are gone with the wind and thats a good thing clean up that part of the market for sure. Too many pumpers and dumpers taking advantage of those that dont know the ugly part of market making and the games they can play. If a Co cant report then they should not have shareholders imo..
Thank God did he give the recipe for the secret sauce? That alone is worth 50 % devaluation of the stock value that was just lost since his conference call. Great stuff that sauce must be spicy.
We covered our puts and reversed to buy this lil pop up we wont be here for a long time just a lil pop to make some more . I hate to say it but NIO has many outside forces that will take the price lower. Good luck NIO has been a great trading vehicle to make us a huge sum of money this yr but Im thinkuing after today we will stay far away from any long positions on NIO. have a great day and Ho ho ho Merry Christmas
This is who the smart money is here at PMCB::https://money.cnn.com/quote/shareholders/shareholders.html?symb=PMCB&subView=institutional
Well lets see NIO was 43.00 plus this day and some buying or lying.
"I am taking some of these cheapies thank you very much!" sure lol. I think its time to go fishing for some snook the muskies are gone and dying from the toxic waters... have a great day and be careful of the sharks lol
yes very good Hung dumped shares at the low. Ho Ho Ho have a Merry Christmas. Very good things are going to happen for PMCB and all the people that bought PMCB at this discounted price.
BZ: PharmaCyte Biotech Reports Q2 2021 Cash On Hand $87M
PharmaCyte Biotech Successfully Completes Cytochrome P450 Site of Integration DNA Sequencing Assay
PharmaCyte Biotech Launches Malignant Ascites Program with Commencement of Pivotal Preclinical Study
PharmaCyte Biotech Says Test Data Show CypCaps Encapsulation Material Safe
Who is they? The institutions are buying a discounted stock price and they know that. We have cash that puts PMCB value at $4.15. If one reads the pr today it states that they have 87 million dollars on hand. That times the stock price gives a buyer a great deal on the price and I wouldn't be surprised to see PMCB buy back shares now with all the cash we now have.
lmao 64 cents to 5.00 not going to happen guess who just got a letter from the FDA and it wasnt a good letter. Maybe TMDI is a buy next week around .40 after the dust settles.
I dont think they wants to do that lol. I think that a stock buyback is what you would see next if they are trading at a discount to cash as they reported 87 million cash on hand today. This is Wall Street now not the ho ho trail. Have a great day and enjoy Xmas season. Its time for brotherly love and good tidings
NIO HAS broke 30.00 to the downside. I warned all that this was going to happen. Down another 2.50 today. Be very careful Im thinking delisting could happen and then how would you be able to get any money back. I told all to watch our trades here and we are loaded with puts. Have a great day time to go fishing lol
BZ: PharmaCyte Biotech Reports Q2 2021 Cash On Hand $87M. At todays price we are a good take over play. We have 4.15 or so per shares of cash so we are trading at a discount per cash on hand per share of 1.75 per share. That alone is going to give us a buy rating soon and more institutional buyers. The list is long already of institutions holding shares of PMCB. Here is a link to see the the holdings:https://money.cnn.com/quote/shareholders/shareholders.html?symb=PMCB&subView=institutional
Have a great day...................
The FDA provided KW with a nio list that is close to completed lmao. Have a great day ...................
Austrianova presented it’s Cell-in-a-Box and Bac-in-a-Box technologies at the Real tech Year End Party, an online event held yesterday
wow huge score here for my Son. The kid has the magic touch.....I wont play the pinkies but he will. Man from under .02 to .50 I did make him sell half. $$$$$
News just hit the wire: PharmaCyte Biotech Successfully Completes Cytochrome P450 Site of Integration DNA Sequencing Assay
One step closer to getting the hold lifted by the FDA and this one was a big one$$$$$
Announced today the results of an additional, more detailed, analysis of the integration site of the cytochrome P450 2B1 gene from the augmented HEK293 cell clone that PharmaCyte uses in its CypCap™ product. This assay is one of the assays required by the U.S. Food and Drug Administration (FDA) in order to have the FDA’s clinical hold lifted on PharmaCyte’s Investigational New Drug Application (IND) for the treatment of locally advanced, inoperable pancreatic cancer (LAPC).
PharmaCyte’s Chief Executive Officer, Kenneth L. Waggoner , said, “We are elated to have completed this sequencing assay given its importance to the FDA, and how incredibly difficult it was to arrive at this successful conclusion. We can report that the DNA sequence analysis of the cytochrome P450 2B1 augmented cells is now complete, and it is a great challenge that is now behind us. This kind of analysis is technically demanding, and we spent a great deal of time getting this right. In addition to extending our characterization of the augmented cells, the data also verifies our previous studies on the cells that are the active component of our novel LAPC therapy.”
In previous studies, PharmaCyte showed that the cytochrome P450 2B1 gene in the augmented HEK293 cell clone was located on human chromosome 9 and the flanking sequence had already been determined. The FDA requested that the exact sequence of the cytochrome P450 2B1 gene inserted at that location should also be determined. This is technologically challenging because the introduced DNA is large and concatenated, causing the Company to turn to nanopore sequencing technology for this analysis. Nanopore sequencing is a cutting edge, unique and scalable technology that enables direct, real-time analysis of long DNA fragments. The technology was successfully used to determine the sequence of the introduced DNA, and the analysis of the sequence data shows that it is both intact and complete.
Great to see one of the Top Wall Street Billionaires wizards has bought 88000 shares of PMCB along with some other institutions. Last yr his firm only made about 37 million in profits lol.
Latest Institutional Activity
10/27/2021 IROQUOIS CAPITAL MANAGEMENT LLC Bought 1.0 Million shares of PharmaCyte Biotech Inc
9/30/2021 SABBY CAPITAL LLC Bought 1.0 Million shares of PharmaCyte Biotech Inc
9/30/2021 T. ROWE PRICE ASSOCIATES, INC. (... Bought 133.6 Thousand shares of PharmaCyte Biotech Inc
Top 10 Owners of PharmaCyte Biotech Inc
Stockholder Stake Shares
owned Total value ($) Shares
Iroquois Capital Management LLC 5.06% 1,048,646 2,715,993 +1,048,646 --
Sabby Capital LLC 4.88% 1,010,146 2,616,278 +1,010,146 --
T. Rowe Price Associates, Inc. (I... 0.65% 133,600 346,024 +133,600 --
[b]Schonfeld Strategic Advisors LLC 0.43% 88,200 228,438 +88,200 --
Susquehanna Investment Group LLC 0.24% 49,700 128,723 +49,700 --
Geode Capital Management LLC 0.23% 46,610 120,720 +46,610 --
NorthRock Partners LLC 0.18% 37,164 96,255 +37,164 --
Shay Capital LLC 0.07% 14,606 37,830 +14,606 --
Tower Research Capital LLC 0.03% 7,070 18,311 +7,070 --
UBS Securities LLC 0.02% 3,390 8,780 +3,390 --
Top 10 Mutual Funds Holding PharmaCyte Biotech Inc
Mutual fund Stake Shares
owned Total value ($) Shares
T Rowe Price Extended Equity Mark... 0.27% 55,500 143,745 +55,500 --
AST T Rowe Price Growth Opportuni... 0.20% 41,700 108,003 0 0.00%
Fidelity Nasdaq Composite Index F... 0.13% 26,211 67,886 0 0.00%
Fidelity Extended Market Index Fu... 0.12% 24,616 63,755 +24,616 --
Fidelity Total Market Index Fund 0.01% 2,452 6,351 +2,452 --
Vanguard Invt. Fds. ICVC - US Equ... 0.01% 2,105 5,452 0 0.00%